Rotor mapping: black box or very simple? The FIRM approach

Area of Science:

• Electrophysiology
• Cardiovascular Medicine
• Medical Technology

Background:

• Catheter ablation is a primary treatment for atrial fibrillation (AF), but outcomes, particularly for persistent AF, are often suboptimal.
• Conventional pulmonary vein isolation (PVI) has limitations in addressing the complex mechanisms of AF.
• Persistent AF requires advanced strategies beyond standard PVI for improved long-term success.

Purpose of the Study:

• To introduce Focal Impulse and Rotor Modulation (FIRM) as a novel technology for mapping and ablating patient-specific AF sources.
• To evaluate the potential of FIRM-guided ablation to improve outcomes in patients with atrial fibrillation.
• To highlight the need for further investigation into FIRM's efficacy, especially in persistent AF cases.

Main Methods:

• FIRM technology utilizes advanced mapping to identify localized sources driving AF, such as rotational waves or focal impulses.
• This approach guides ablation strategies aimed at eliminating these identified patient-specific AF drivers.
• Studies reviewed include primarily single-center case series examining FIRM-guided ablation combined with PVI.

Main Results:

• Single-center studies suggest that adding FIRM-guided ablation to PVI may offer incremental benefits for long-term outcomes in AF patients.
• FIRM's ability to target organized rotational waves and focal impulses represents a new paradigm in AF ablation.
• Observed improvements indicate potential for FIRM in managing complex AF, including persistent forms.

Conclusions:

• FIRM-guided ablation shows promise as an adjunctive therapy to PVI for improving atrial fibrillation treatment outcomes.
• The concept of targeting localized AF sources with FIRM warrants further clinical validation.
• Results from ongoing multicenter randomized trials are crucial to establish FIRM's role in routine AF management.